Structure Info
- Chemspace ID
- CSCS00015573309 (Synthesis)
- CAS
- 1383823-45-7
- MFCD
- MFCD29763003
- IUPAC Name
- {bicyclo[4.1.0]heptan-3-yl}methanol
- Mol formula
- C8H14O
- Mol weight
- 126 Da
- Catalog Number(s)
- A1082696, AR01C4TG, AT14844, AT14844-0.25G, AW44632, ArZ-UP179681, ArZ-UP215839, BB4LS-EN300-257843, BBV-38186624, BD01051947, CSC015573309, EN300-257843, IFC82345, LN05000400, Y3228352, ZX-NM193554, ZX-NM222956
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.26
- Heavy atoms count
- 9
- Rotatable bond count
- 1
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 1
- Polar surface area (Å)
- 20
- Hydrogen bond acceptors count
- 1
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS00015573309
Items Overall 12 items from 4 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 250 mg | 422 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 1 g | 836 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 5 g | 2,510 | |
Description: Name:{bicyclo[4.1.0]heptan-3-yl}methanol; CAS: 1383823-45-7 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 250 mg | 422 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 1 g | 836 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 5 g | 2,510 | |
Description: Name:{bicyclo[4.1.0]heptan-3-yl}methanol; CAS: 1383823-45-7 | ||||||
| eNovation CN | 40 days | China To: | 95 | 50 mg | 218 | |
| eNovation CN | 40 days | China To: | 95 | 100 mg | 299 | |
| eNovation CN | 40 days | China To: | 95 | 250 mg | 420 | |
| eNovation CN | 40 days | China To: | 95 | 500 mg | 765 | |
| eNovation CN | 40 days | China To: | 95 | 1 g | 989 | |
Description: {bicyclo[4.1.0]heptan-3-yl}methanol; CAS: 1383823-45-7 | ||||||
| Astatech Inc | TBD | United States To: | 95 | 1 g | POA | |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire